1983
DOI: 10.1177/030098588302000609
|View full text |Cite
|
Sign up to set email alerts
|

The Effects of Dietary T-2 Toxin on Acute Herpes Simplex Virus Type 1 Infection in Mice

Abstract: Abstract. Young male white Swiss mice were fed control diet or diet supplemented with 20 or 10 parts per million (ppm) of T-2 toxin for two or three weeks. These mice then were inoculated with herpes simplex virus type I (HSV-1) (9.6 X lo6 plaque forming units) intraperitoneally. To compare the effects of T-2 toxin against a known immunosuppressive drug, cyclophosphamide was injected intraperitoneally at I50 mg/kg, 24 hours after treatment with HSV-1. into mice fed the control diet. Mice were necropsied and ti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1985
1985
2016
2016

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 26 publications
(2 citation statements)
references
References 33 publications
(17 reference statements)
0
2
0
Order By: Relevance
“…and oral exposure to the toxin induces apoptosis of hematopoietic and lymphoid tissues, including bone marrow, Peyer's patches, spleen, and thymus (Ihara et al, 1997;Shinozuka et al, 1997aShinozuka et al, , 1997bIslam et al, 1998;Nagata et al, 2001). Experimental animals similarly treated with T-2 are Toxicology and Applied Pharmacology 214 (2006) 318 -325 www.elsevier.com/locate/ytaap more susceptible to systemic infections by Salmonella Typhimurium (Tai and Pestka, 1990;Ziprin and Elissalde, 1990;Kubena et al, 2001), Listeria monocytogenes (Ziprin and McMurray, 1988;Ziprin et al, 1987), Babesia microti (Corrier and Wagner, 1988), Mycobacterium (Kanai and Kondo, 1984;Ziprin and McMurray, 1988), and Herpes simplex virus (Friend et al, 1983). Although the intestine is a principal target in ATA, little is known of T-2′s capacity to suppress the gut mucosal immune response.…”
Section: Introductionmentioning
confidence: 99%
“…and oral exposure to the toxin induces apoptosis of hematopoietic and lymphoid tissues, including bone marrow, Peyer's patches, spleen, and thymus (Ihara et al, 1997;Shinozuka et al, 1997aShinozuka et al, , 1997bIslam et al, 1998;Nagata et al, 2001). Experimental animals similarly treated with T-2 are Toxicology and Applied Pharmacology 214 (2006) 318 -325 www.elsevier.com/locate/ytaap more susceptible to systemic infections by Salmonella Typhimurium (Tai and Pestka, 1990;Ziprin and Elissalde, 1990;Kubena et al, 2001), Listeria monocytogenes (Ziprin and McMurray, 1988;Ziprin et al, 1987), Babesia microti (Corrier and Wagner, 1988), Mycobacterium (Kanai and Kondo, 1984;Ziprin and McMurray, 1988), and Herpes simplex virus (Friend et al, 1983). Although the intestine is a principal target in ATA, little is known of T-2′s capacity to suppress the gut mucosal immune response.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, T-2 toxin has been reported to induce apoptosis in thymus, hematopoietic tissues and HL-60 human promyelocytic leukemia cells (26,56,73). Repeated exposure to T-2 toxin also causes immunosuppression and decreases the resistance of exposed animals to various infectious diseases such as Newcastle disease (29), salmonellosis, and Cryptosporidiosis in chickens (3,4,5) and mice (60, 61,76), and tuberculosis (76), listeriosis (13), Toxoplasma gondii, and herpes simplex infection in mice (17,63). In addition, T-2 toxin may impair host control of tumor cell growth (11,52,53).…”
mentioning
confidence: 99%